These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34550460)

  • 1. Improving the safety of outpatient parenteral antimicrobial therapy for patients with solid tumors.
    Robins A; Dishner E; McDaneld P; Rowan M; Bartek J; Jiang Y; Adachi J; Dailey Garnes NJM
    Support Care Cancer; 2022 Feb; 30(2):1643-1654. PubMed ID: 34550460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Close Patient Follow-up Among Patients Receiving Outpatient Parenteral Antimicrobial Therapy.
    Palms DL; Jacob JT
    Clin Infect Dis; 2020 Jan; 70(1):67-74. PubMed ID: 30810165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of laboratory test result availability and rehospitalizations in an outpatient parenteral antimicrobial therapy programme.
    Huck D; Ginsberg JP; Gordon SM; Nowacki AS; Rehm SJ; Shrestha NK
    J Antimicrob Chemother; 2014 Jan; 69(1):228-33. PubMed ID: 23887864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring of Outpatient Parenteral Antimicrobial Therapy and Implementation of Clinical Pharmacy Services at a Community Hospital Infusion Unit.
    Shah PJ; Bergman SJ; Graham DR; Glenn S
    J Pharm Pract; 2015 Oct; 28(5):462-8. PubMed ID: 25107418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifungal use via outpatient parenteral antimicrobial therapy.
    Chew SM; Heath CH; Petursson C; Boan PA; Robinson JO; Italiano CM; Dyer JR; Manning L; Ingram PR
    Mycoses; 2022 Oct; 65(10):946-952. PubMed ID: 35923125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-Administered Outpatient Antimicrobial Infusion by Uninsured Patients Discharged from a Safety-Net Hospital: A Propensity-Score-Balanced Retrospective Cohort Study.
    Bhavan KP; Brown LS; Haley RW
    PLoS Med; 2015 Dec; 12(12):e1001922. PubMed ID: 26671467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for readmission among patients receiving outpatient parenteral antimicrobial therapy: a retrospective cohort study.
    Douiyeb S; de la Court JR; Tuinte B; Sombogaard F; Schade RP; Kuijvenhoven M; Minderhoud T; Sigaloff KCE
    Int J Clin Pharm; 2022 Apr; 44(2):557-563. PubMed ID: 35157228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial stewardship in the outpatient parenteral antimicrobial therapy (OPAT) setting: the impact of prescription assessment by an infectious diseases specialist.
    Cassettari V; Novato N; Onuchic MHF
    Braz J Infect Dis; 2021; 25(2):101560. PubMed ID: 33716018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External validity and clinical usefulness of a risk prediction model for 30 day unplanned hospitalization in patients receiving outpatient parenteral antimicrobial therapy.
    Durojaiye OC; Morgan R; Chelaghma N; Palit J; Keil C; Omer R; Cartwright K; Kritsotakis EI
    J Antimicrob Chemother; 2021 Jul; 76(8):2204-2212. PubMed ID: 33895844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of outpatient parenteral antibiotic therapy in patients with infective endocarditis: a meta-analysis.
    Wen W; Li H; Wang C; Chen C; Tang J; Zhou M; Hong X; Cheng Y; Wu Q; Zhang X; Feng Z; Wang M
    Rev Esp Quimioter; 2022 Aug; 35(4):370-377. PubMed ID: 35652306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure modes and effects analysis to improve transitions of care in patients discharged on outpatient parenteral antimicrobial therapy.
    Sadler ED; Avdic E; Cosgrove SE; Hohl D; Grimes M; Swarthout M; Dzintars K; Lippincott CK; Keller SC
    Am J Health Syst Pharm; 2021 Jun; 78(13):1223-1232. PubMed ID: 33944904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mandatory infectious diseases approval of outpatient parenteral antimicrobial therapy (OPAT): clinical and economic outcomes of averted cases.
    Conant MM; Erdman SM; Osterholzer D
    J Antimicrob Chemother; 2014 Jun; 69(6):1695-700. PubMed ID: 24532684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of a Belgian tertiary care outpatient parenteral antimicrobial therapy (OPAT) program.
    Quintens C; Steffens E; Jacobs K; Schuermans A; Van Eldere J; Lagrou K; De Munter P; Derdelinckx I; Peetermans WE; Spriet I
    Infection; 2020 Jun; 48(3):357-366. PubMed ID: 32060859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful implementation of outpatient parenteral antimicrobial therapy at a medical respite facility for homeless patients.
    Beieler AM; Dellit TH; Chan JD; Dhanireddy S; Enzian LK; Stone TJ; Dwyer-O'Connor E; Lynch JB
    J Hosp Med; 2016 Aug; 11(8):531-5. PubMed ID: 27120700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of a multidisciplinary team review of potential outpatient parenteral antimicrobial therapy prior to discharge from an academic medical center.
    Heintz BH; Halilovic J; Christensen CL
    Ann Pharmacother; 2011 Nov; 45(11):1329-37. PubMed ID: 21990938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective analysis of outcomes of outpatient parenteral antimicrobial therapy (OPAT) for necrotising otitis externa.
    Durojaiye OC; Slucka A; Kritsotakis EI
    Eur J Clin Microbiol Infect Dis; 2022 Jun; 41(6):941-949. PubMed ID: 35556187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Quality Initiative to Improve Postdischarge Care for Patients on Outpatient Parenteral Antimicrobial Therapy.
    Certain LK; Benefield RJ; Newman M; Zhang M; Thomas FO
    Open Forum Infect Dis; 2022 Jul; 9(7):ofac199. PubMed ID: 35794930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of Hospital Readmission in Patients Receiving Outpatient Parenteral Antimicrobial Therapy.
    Means L; Bleasdale S; Sikka M; Gross AE
    Pharmacotherapy; 2016 Aug; 36(8):934-9. PubMed ID: 27393717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the implementation of a nurse-managed outpatient parenteral antibiotic therapy (OPAT) system in Baltimore: a case study demonstrating cost savings and reduction in re-admission rates.
    Mansour O; Heslin J; Townsend JL
    J Antimicrob Chemother; 2018 Nov; 73(11):3181-3188. PubMed ID: 30085088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of an Infectious Diseases Transition Service on the Care of Outpatients on Parenteral Antimicrobial Therapy.
    Keller SC; Ciuffetelli D; Bilker W; Norris A; Timko D; Rosen A; Myers JS; Hines J; Metlay J
    J Pharm Technol; 2013 Oct; 29(5):205-214. PubMed ID: 25621307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.